ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 130 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9 | -18.2% | 2,673 | 0.0% | 0.00% | – |
| Q1 2024 | $11 | -47.6% | 2,673 | -60.5% | 0.00% | – |
| Q4 2023 | $21 | -8.7% | 6,775 | -10.5% | 0.00% | – |
| Q3 2023 | $23 | -17.9% | 7,570 | 0.0% | 0.00% | – |
| Q2 2023 | $28 | +3.7% | 7,570 | -4.5% | 0.00% | – |
| Q1 2023 | $27 | -42.6% | 7,927 | -18.2% | 0.00% | – |
| Q4 2022 | $47 | -99.9% | 9,696 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $55,000 | -20.3% | 9,696 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $69,000 | +19.0% | 9,696 | +20.0% | 0.00% | – |
| Q1 2022 | $58,000 | -81.2% | 8,080 | -7.9% | 0.00% | -100.0% |
| Q3 2021 | $308,000 | +53.2% | 8,773 | -6.2% | 0.00% | +50.0% |
| Q2 2021 | $201,000 | – | 9,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 5,462,079 | $16,659,341 | 12.62% |
| TANG CAPITAL MANAGEMENT LLC | 4,076,741 | $12,434,060 | 1.15% |
| Stonepine Capital Management, LLC | 839,514 | $2,560,518 | 1.11% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,581,196 | 0.73% |
| CM Management, LLC | 270,000 | $823,500 | 0.66% |
| EcoR1 Capital, LLC | 6,995,861 | $21,337,376 | 0.55% |
| Acuitas Investments, LLC | 171,098 | $615,373 | 0.32% |
| Newtyn Management, LLC | 508,474 | $1,550,846 | 0.30% |
| Diametric Capital, LP | 161,524 | $492,648 | 0.30% |
| Auour Investments LLC | 177,000 | $670,830 | 0.26% |